BM Bureau, May 13 : In a third increase in interval for Covishield since the vaccination drive was started in January, the recommended four to six weeks & four to eight weeks gap has been now extended from 12 to 16 weeks.
The Union Health Ministry on Thursday approved the gap between the first dose and the second dose of a Covid-19 vaccine Covishield based on the recommendation of expert panel. The National Technical Advisory Group on Immunisation (NTAGI) had recommended that the gap between the two doses of Covishield can be further extended to 12 to 16 weeks.
No such changes were recommended in the intervals of Bharat Biotech’s Covaxin. Experts say that Covaxin has been developed using a “dead virus, which is incapable of infecting people but still able to instruct the immune system to mount a defensive action against an infection”. There is no data on whether the effectiveness increases if the gap is widened as during the trial.




















